Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Cash & Equivalents	314.1	126.15	457.41	647.25	739.66	372.47
Trading Asset Securities	177.5	210	-	-	-	-
Cash & Short-Term Investments	491.6	336.15	457.41	647.25	739.66	372.47
Cash Growth	55.87%	-26.51%	-29.33%	-12.49%	98.58%	-35.24%
Accounts Receivable	221.14	253.59	205.32	156	133.02	126.66
Other Receivables	1.73	0.8	9.38	13.94	16.87	1.36
Receivables	222.87	254.39	214.7	169.94	149.9	128.02
Inventory	252	237.63	264.38	271.83	208.23	195.31
Prepaid Expenses	-	-	-	-	-	0.69
Other Current Assets	35.07	29.43	14.46	16.13	31.08	15.45
Total Current Assets	1,002	857.6	950.95	1,105	1,129	711.95
Property, Plant & Equipment	718.88	733.31	721.4	656.49	648.01	601.68
Long-Term Investments	13.5	13.5	13.5	13.5	13.5	-
Goodwill	517.6	517.6	517.6	529.23	542.4	542.4
Other Intangible Assets	131.84	141.22	138.63	151.24	153.87	156.75
Long-Term Deferred Tax Assets	23.13	28.43	21.85	18.4	18.81	17.18
Long-Term Deferred Charges	12.27	7.29	17.41	13.45	11.48	15.6
Other Long-Term Assets	21.89	12.47	19.54	25.18	28.67	20.65
Total Assets	2,441	2,311	2,401	2,513	2,546	2,066

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Accounts Payable	70.33	68.63	44.83	83	76.29	52.35
Accrued Expenses	8.55	40.62	19.37	32.5	30.42	20.09
Short-Term Debt	387.46	263.54	516.09	306	633.68	377
Current Portion of Long-Term Debt	-	-	-	-	213.5	-
Current Income Taxes Payable	16.95	3.92	0.72	13.65	4.86	8.59
Current Unearned Revenue	24.06	62.18	11.05	24.26	130.69	31.06
Other Current Liabilities	96.87	15.45	3.96	6.36	19.81	7.25
Total Current Liabilities	604.23	454.33	596.02	465.77	1,109	496.34
Long-Term Debt	-	-	-	-	-	285.18
Long-Term Unearned Revenue	17.4	17.27	20.57	20.77	18.51	11.72
Long-Term Deferred Tax Liabilities	18.2	18.36	19.36	15.42	14.71	11.27
Total Liabilities	639.83	489.96	635.94	501.95	1,142	804.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Common Stock	513.31	513.31	512.21	364.69	229.18	221.64
Additional Paid-In Capital	854.62	849.97	844.13	982	575.92	460.91
Retained Earnings	525.43	552.53	495.8	657.68	553.51	519.38
Treasury Stock	-99.51	-101.19	-93.86	-	-	-
Comprehensive Income & Other	6.97	6.85	6.65	6.31	44.53	59.75
Shareholders' Equity	1,801	1,821	1,765	2,011	1,403	1,262
Total Liabilities & Equity	2,441	2,311	2,401	2,513	2,546	2,066

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Total Debt	387.46	263.54	516.09	306	847.18	662.18
Net Cash (Debt)	104.13	72.61	-58.68	341.25	-107.52	-289.71
Net Cash Growth	87.97%	-	-	-	-	-
Net Cash Per Share	0.21	0.14	-0.11	0.74	-0.25	-0.72
Filing Date Shares Outstanding	510.74	499.58	500.58	510.56	449.27	434.42
Total Common Shares Outstanding	510.74	499.58	499.49	510.56	449.19	434.42
Working Capital	397.31	403.27	354.93	639.39	19.62	215.61
Book Value Per Share	3.53	3.65	3.53	3.94	3.12	2.90
Tangible Book Value	1,151	1,163	1,109	1,330	706.87	562.55
Tangible Book Value Per Share	2.25	2.33	2.22	2.61	1.57	1.29
Buildings	-	608.2	527.78	542.22	412.29	419.33
Machinery	-	439.2	418.7	329.97	259.01	254.01
Construction In Progress	-	118.38	157.88	131.95	280.88	198.46

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error